{"id":76748,"date":"2026-10-28T20:13:20","date_gmt":"2026-10-28T20:13:20","guid":{"rendered":"https:\/\/www.stocktargetadvisor.com\/blog\/?p=76748"},"modified":"2026-10-28T20:13:20","modified_gmt":"2026-10-28T20:13:20","slug":"american-analyst-updates-oct-28th-2026","status":"publish","type":"post","link":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/","title":{"rendered":"American Analyst Updates: Oct 28th, 2026"},"content":{"rendered":"

Analyst Ratings (USA)<\/a><\/h2>\n

Today’s updates reflect a selective analyst outlook, with confidence in software, semiconductors and payments sectors, offset by caution toward industrials, solar energy and consumer durables. Higher targets in consumer staples and travel added pockets of optimism, while downgrades and target cuts elsewhere signalled more restrained expectations. Analysts frequently retained positive ratings despite lowering targets, suggesting continued longer-term confidence alongside near-term caution.<\/p>\n

Updates (497)<\/strong><\/h3>\n

Acadian Asset Management (AAMI)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$97.00 from US$95.00.<\/p>\n

Aclaris Therapeutics (ACRS)<\/strong> \u2014 Craig Hallum set a price target to US$9.00.<\/p>\n

Aclaris Therapeutics (ACRS)<\/strong> \u2014 HC Wainwright reiterated its Buy rating with a price target of US$16.00.<\/p>\n

Adagene (ADAG)<\/strong> \u2014 Chardan Capital reiterated its Buy rating with a price target of US$9.00.<\/p>\n

Advanced Micro Devices (AMD)<\/strong> \u2014 Susquehanna maintained its Positive rating and raised its price target to US$650.00 from US$620.00.<\/p>\n

AerSale (ASLE)<\/strong> \u2014 B. Riley Financial maintained its Neutral rating and lowered its price target to US$6.00 from US$7.50.<\/p>\n

Alexandria Real Estate Equities (ARE)<\/strong> \u2014 BNP Paribas Exane maintained its Underperform rating and lowered its price target to US$37.00 from US$40.00.<\/p>\n

Alexandria Real Estate Equities (ARE)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$42.00 from US$52.00.<\/p>\n

Algonquin Power & Utilities (AQN)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a price target to US$5.75.<\/p>\n

Alignment Healthcare (ALHC)<\/strong> \u2014 Needham & Company LLC initiated coverage with a Hold rating.<\/p>\n

AllianceBernstein (AB)<\/strong> \u2014 Sanford C. Bernstein reiterated its Hold rating with a price target of US$35.00.<\/p>\n

AllianceBernstein (AB)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$35.00 from US$36.00.<\/p>\n

Alnylam Pharmaceuticals (ALNY)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Alpine Income Property Trust (PINE)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and lowered its price target to US$20.00 from US$22.00.<\/p>\n

Amentum (AMTM)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$25.00 from US$26.00.<\/p>\n

American Public Education (APEI)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$65.00 from US$70.00.<\/p>\n

American Tower (AMT)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating with a price target of US$205.00.<\/p>\n

Ameris Bancorp (ABCB)<\/strong> \u2014 Truist Financial maintained its Hold rating and raised its price target to US$87.00 from US$84.00.<\/p>\n

Amphenol (APH)<\/strong> \u2014 Evercore set a price target to US$100.00.<\/p>\n

Anfield Energy (AEC)<\/strong> \u2014 Roth Capital initiated coverage with a Buy rating with a price target of US$5.<\/p>\n

Apple (AAPL)<\/strong> \u2014 Monness Crespi & Hardt reiterated its Buy rating with a price target of US$355.00.<\/p>\n

Applied Aerospace & Defense (AADX)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$18.00 from US$21.00.<\/p>\n

Applied Industrial Technologies (AIT)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to US$360.00 from US$420.00.<\/p>\n

Applied Industrial Technologies (AIT)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

Applied Industrial Technologies (AIT)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and lowered its price target to US$350.00 from US$400.00.<\/p>\n

AppLovin (APP)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$500.00 from US$575.00.<\/p>\n

AppLovin (APP)<\/strong> \u2014 UBS Group set a price target to US$414.00.<\/p>\n

Arch Capital Group (ACGL)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

Ares Capital (ARCC)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

Armstrong World Industries (AWI)<\/strong> \u2014 DA Davidson set a price target to US$200.00.<\/p>\n

Armstrong World Industries (AWI)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a price target of US$225.00.<\/p>\n

Armstrong World Industries (AWI)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to US$210.00 from US$230.00.<\/p>\n

Asbury Automotive Group (ABG)<\/strong> \u2014 Bank of America reiterated its Buy rating with a price target of US$232.00.<\/p>\n

Atlas Energy Solutions (AESI)<\/strong> \u2014 Glj Research initiated coverage with a Buy rating with a price target of US$13.00.<\/p>\n

Atlassian (TEAM)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$270.00 from US$230.00.<\/p>\n

Avidbank (AVBH)<\/strong> \u2014 DA Davidson maintained its Buy rating and raised its price target to US$40.00 from US$38.00.<\/p>\n

Avidity Biosciences (RNA)<\/strong> \u2014 HC Wainwright maintained its Buy rating and lowered its price target to US$20.00 from US$25.00.<\/p>\n

BankUnited (BKU)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$44.00 from US$47.00.<\/p>\n

Beam Therapeutics (BEAM)<\/strong> \u2014 Wedbush maintained its Outperform rating and lowered its price target to US$28.00 from US$65.00.<\/p>\n

Beta Bionics (BBNX)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating with a price target of US$24.00 from US$20.00.<\/p>\n

Beta Bionics (BBNX)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$21.00 from US$18.00.<\/p>\n

BigBear.ai (BBAI)<\/strong> \u2014 Cantor Fitzgerald maintained its Neutral rating and lowered its price target to US$3.00 from US$4.00.<\/p>\n

BigBear.ai (BBAI)<\/strong> \u2014 Citigroup reiterated its Market Perform rating.<\/p>\n

Biogen (BIIB)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to US$230.00 from US$200.00.<\/p>\n

Biogen (BIIB)<\/strong> \u2014 Citigroup reiterated its Neutral rating.<\/p>\n

BlackRock (BLK)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating with a price target of US$1,341.00.<\/p>\n

Block (XYZ)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a price target of US$100.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$250.00 from US$300.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 BNP Paribas Exane maintained its Outperform rating and lowered its price target to US$205.00 from US$265.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 BNP Paribas Exane upgraded the stock to Neutral.<\/p>\n

Boeing (BA)<\/strong> \u2014 Glj Research initiated coverage with a Buy rating.<\/p>\n

Boeing (BA)<\/strong> \u2014 Jefferies Financial Group set a price target to US$230.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$195.00 from US$225.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 Needham & Company LLC initiated coverage with a Hold rating.<\/p>\n

Boeing (BA)<\/strong> \u2014 Oppenheimer downgraded the stock to Market Perform.<\/p>\n

Boeing (BA)<\/strong> \u2014 Piper Sandler downgraded the stock from Overweight to Neutral.<\/p>\n

Boeing (BA)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and lowered its price target to US$230.00 from US$300.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 Roth Capital downgraded the stock to Neutral.<\/p>\n

Boeing (BA)<\/strong> \u2014 Susquehanna initiated coverage with a Positive rating with a price target of US$250.00 from US$285.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$210.00 from US$240.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a price target of US$238.00.<\/p>\n

Boeing (BA)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

Boeing (BA)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$210.00 from US$250.00.<\/p>\n

Boston Scientific (BSX)<\/strong> \u2014 JPMorgan downgraded the stock from Overweight to Neutral with a price target of US$46.<\/p>\n

Boston Scientific (BSX)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and lowered its price target to US$48.00 from US$57.00.<\/p>\n

Brookfield Business (BBUC)<\/strong> \u2014 National Bank Financial maintained its Outperform rating and lowered its price target to US$38.00 from US$42.00.<\/p>\n

Brown & Brown (BRO)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to US$85.00 from US$90.00.<\/p>\n

Byline Bancorp (BY)<\/strong> \u2014 Stephens maintained its Equal Weight rating and raised its price target to US$42.00 from US$40.00.<\/p>\n

C4 Therapeutics (CCCC)<\/strong> \u2014 Lake Street Capital initiated coverage with a Buy rating with a price target of US$11.00.<\/p>\n

CAE (CAE)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating.<\/p>\n

Camden National (CAC)<\/strong> \u2014 National Bank Financial set a price target to US$58.00.<\/p>\n

Canada Goose (GOOS)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a price target of US$9.00.<\/p>\n

Carvana (CVNA)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

Cavco Industries (CVCO)<\/strong> \u2014 Northland Securities initiated coverage with a Outperform rating with a price target of US$650.00.<\/p>\n

Celcuity (CELC)<\/strong> \u2014 Royal Bank Of Canada downgraded the stock to Neutral.<\/p>\n

Celestica (CLS)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$414.00 from US$406.00.<\/p>\n

Celestica (CLS)<\/strong> \u2014 Citigroup reiterated its Buy rating with a price target of US$436.00 from US$415.00.<\/p>\n

Celestica (CLS)<\/strong> \u2014 The Goldman Sachs Group reiterated its Conviction-Buy rating with a price target of US$435.00.<\/p>\n

Cementos Pacasmayo S.A.A. (CPAC)<\/strong> \u2014 Scotiabank maintained its Sector Perform rating and lowered its price target to US$12.96 from US$13.00.<\/p>\n

Centene (CNC)<\/strong> \u2014 Bank of America reiterated its Buy rating with a price target of US$82.00 from US$80.00.<\/p>\n

Centene (CNC)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$82.00 from US$80.00.<\/p>\n

Centene (CNC)<\/strong> \u2014 Cantor Fitzgerald maintained its Overweight rating and raised its price target to US$79.00 from US$75.00.<\/p>\n

Centene (CNC)<\/strong> \u2014 Mizuho set a price target to US$72.00.<\/p>\n

Centene (CNC)<\/strong> \u2014 Morgan Stanley assigned a Equal Weight rating and set a price target to US$71.00 from US$66.00.<\/p>\n

Centene (CNC)<\/strong> \u2014 Raymond James Financial set a price target to US$79.00.<\/p>\n

Centene (CNC)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to US$71.00 from US$66.00.<\/p>\n

CenterPoint Energy (CNP)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to US$43.00 from US$41.00.<\/p>\n

Central Bancompany (CBC)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to US$40.00 from US$37.00.<\/p>\n

Centrus Energy (LEU)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$188.00 from US$295.00.<\/p>\n

Charles Schwab (SCHW)<\/strong> \u2014 Evercore set a price target to US$98.00.<\/p>\n

Cheesecake Factory (CAKE)<\/strong> \u2014 Stephens reiterated its Equal Weight rating with a price target of US$100.00.<\/p>\n

Cheesecake Factory (CAKE)<\/strong> \u2014 Wells Fargo & Company set a price target to US$116.00.<\/p>\n

Chemed (CHE)<\/strong> \u2014 Jefferies Financial Group upgraded the stock from Hold to Buy with a price target of US$620.00.<\/p>\n

Chubb (CB)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$379.00 from US$360.00.<\/p>\n

Church & Dwight (CHD)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to US$120.00 from US$115.00.<\/p>\n

Citizens (CIZN)<\/strong> \u2014 Raymond James Financial reiterated its Market Perform rating.<\/p>\n

Cloudflare (NET)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$400.00 from US$380.00.<\/p>\n

Clover Health Investments (CLOV)<\/strong> \u2014 Needham & Company LLC initiated coverage with a Buy rating with a price target of US$6.00.<\/p>\n

CMS Energy (CMS)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$73.00 from US$79.00.<\/p>\n

Coca-Cola (KO)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$98.00 from US$95.00.<\/p>\n

Coca-Cola (KO)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$103.00 from US$100.00.<\/p>\n

Coca-Cola (KO)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$104.00 from US$100.00.<\/p>\n

Coca-Cola (KO)<\/strong> \u2014 UBS Group set a price target to US$106.00.<\/p>\n

Coca-Cola (KO)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$100.00 from US$90.00.<\/p>\n

Colliers International Group (CIGI)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and lowered its price target to US$130.00 from US$145.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 DA Davidson maintained its Buy rating and raised its price target to US$210.00 from US$185.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 Guggenheim maintained its Buy rating and raised its price target to US$200.00 from US$175.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to US$200.00 from US$175.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$180.00 from US$160.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 Scotiabank maintained its Sector Perform rating and raised its price target to US$180.00 from US$160.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 Truist Financial reiterated its Buy rating with a price target of US$200.00 from US$182.00.<\/p>\n

CommVault Systems (CVLT)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$185.00 from US$155.00.<\/p>\n

Connect Biopharma (CNTB)<\/strong> \u2014 HC Wainwright reiterated its Buy rating.<\/p>\n

Corning (GLW)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to US$132.00 from US$129.00.<\/p>\n

Corning (GLW)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$155.00 from US$165.00.<\/p>\n

Corning (GLW)<\/strong> \u2014 Truist Financial reiterated its Buy rating with a price target of US$175.00 from US$182.00.<\/p>\n

Corning (GLW)<\/strong> \u2014 UBS Group reiterated its Buy rating with a price target of US$192.00.<\/p>\n

Corpay (CPAY)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$460.00 from US$455.00.<\/p>\n

CoStar Group (CSGP)<\/strong> \u2014 BTIG Research maintained its Buy rating and lowered its price target to US$35.00 from US$42.00.<\/p>\n

CoStar Group (CSGP)<\/strong> \u2014 Citigroup reiterated its Market Outperform rating.<\/p>\n

CoStar Group (CSGP)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating with a price target of US$40.00.<\/p>\n

CoStar Group (CSGP)<\/strong> \u2014 The Goldman Sachs Group set a price target to US$36.00.<\/p>\n

CoStar Group (CSGP)<\/strong> \u2014 Wells Fargo & Company maintained its Underweight rating and raised its price target to US$26.00 from US$25.00.<\/p>\n

CoStar Group (CSGP)<\/strong> \u2014 Wells Fargo & Company set a price target to US$35.00.<\/p>\n

Cullinan Therapeutics (CGEM)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$41.00 from US$40.00.<\/p>\n

DAQO New Energy (DQ)<\/strong> \u2014 Roth Capital set a price target to US$12.00.<\/p>\n

Datadog (DDOG)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$325.00 from US$295.00.<\/p>\n

Datavault AI (DVLT)<\/strong> \u2014 Maxim Group downgraded the stock from Buy to Hold.<\/p>\n

Ducommun (DCO)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$180.00 from US$200.00.<\/p>\n

Dynatrace (DT)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$75.00 from US$60.00.<\/p>\n

Dyne Therapeutics (DYN)<\/strong> \u2014 Oppenheimer downgraded the stock from Outperform to Market Perform with a price target of US$15.00 from US$40.00.<\/p>\n

Eagle Materials (EXP)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to US$207.00 from US$232.00.<\/p>\n

Ecolab (ECL)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Ecolab (ECL)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$310.00 from US$305.00.<\/p>\n

Ecolab (ECL)<\/strong> \u2014 UBS Group set a price target to US$357.00.<\/p>\n

Eloxx Pharmaceuticals (ELOX)<\/strong> \u2014 Guggenheim maintained its Buy rating and lowered its price target to US$40.00 from US$43.00.<\/p>\n

enCore Energy (EU)<\/strong> \u2014 B. Riley Financial reiterated its Buy rating.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Barclays set a price target to US$26.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and lowered its price target to US$25.00 from US$28.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Craig Hallum set a price target to US$38.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Mizuho set a price target to US$34.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and lowered its price target to US$16.00 from US$24.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Northland Securities set a price target to US$37.50.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Oppenheimer downgraded the stock from Outperform to Market Perform.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Roth Capital downgraded the stock from Buy to Neutral with a price target of US$30.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$30.00 from US$41.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Sanford C. Bernstein maintained its Market Perform rating and lowered its price target to US$40.00 from US$56.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Susquehanna maintained its Neutral rating and lowered its price target to US$26.00 from US$35.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 The Goldman Sachs Group maintained its Buy rating and lowered its price target to US$40.00 from US$47.00.<\/p>\n

Enphase Energy (ENPH)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$34.00 from US$44.00.<\/p>\n

Equinor ASA (EQNR)<\/strong> \u2014 DZ Bank downgraded the stock from Buy to Hold.<\/p>\n

Etsy (ETSY)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$102.00 from US$90.00.<\/p>\n

Etsy (ETSY)<\/strong> \u2014 Deutsche Bank Aktiengesellschaft reiterated its Hold rating.<\/p>\n

Euronet Worldwide (EEFT)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n

Euronet Worldwide (EEFT)<\/strong> \u2014 DA Davidson assigned a Buy rating and set a price target to US$84.00 from US$94.00.<\/p>\n

Euronet Worldwide (EEFT)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$63.00 from US$71.00.<\/p>\n

Excelerate Energy (EE)<\/strong> \u2014 DNB Markets set a price target to US$39.00.<\/p>\n

Exelon (EXC)<\/strong> \u2014 Jefferies Financial Group reiterated its Hold rating.<\/p>\n

ExlService (EXLS)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and raised its price target to US$50.00 from US$45.00.<\/p>\n

F5 (FFIV)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to US$428.00 from US$397.00.<\/p>\n

F5 (FFIV)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

F5 (FFIV)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$448.00 from US$415.00.<\/p>\n

F5 (FFIV)<\/strong> \u2014 Piper Sandler downgraded the stock from Overweight to Neutral with a price target of US$461.00.<\/p>\n

F5 (FFIV)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and raised its price target to US$540.00 from US$525.00.<\/p>\n

F5 (FFIV)<\/strong> \u2014 Wells Fargo & Company set a price target to US$500.00.<\/p>\n

Figma (FIG)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

First Citizens BancShares (FCNCA)<\/strong> \u2014 Truist Financial maintained its Hold rating and raised its price target to US$2,470.00 from US$2,323.00.<\/p>\n

FirstSun Capital Bancorp (FSUN)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$45.00 from US$47.00.<\/p>\n

FirstSun Capital Bancorp (FSUN)<\/strong> \u2014 Stephens maintained its Overweight rating and raised its price target to US$48.00 from US$45.00.<\/p>\n

Five9 (FIVN)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$36.00 from US$32.00.<\/p>\n

Flywire (FLYW)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$24.00 from US$22.00.<\/p>\n

Fortis (FTS)<\/strong> \u2014 Canadian Imperial Bank of Commerce reiterated its Neutral rating.<\/p>\n

Freeport-McMoRan (FCX)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and lowered its price target to US$78.00 from US$80.00.<\/p>\n

Freeport-McMoRan (FCX)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$79.00 from US$87.00.<\/p>\n

Freshworks (FRSH)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$15.00 from US$10.00.<\/p>\n

FTAI Aviation (FTAI)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$250.00 from US$300.00.<\/p>\n

Galaxy Digital (GLXY)<\/strong> \u2014 Canaccord Genuity Group reiterated its Buy rating with a price target of US$50.00.<\/p>\n

Galaxy Digital (GLXY)<\/strong> \u2014 HC Wainwright maintained its Buy rating and lowered its price target to US$36.00 from US$40.00.<\/p>\n

GE HealthCare Technologies (GEHC)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$83.00 from US$75.00.<\/p>\n

GE Vernova (GEV)<\/strong> \u2014 Sanford C. Bernstein reiterated its Outperform rating with a price target of US$1,298.00.<\/p>\n

General Motors (GM)<\/strong> \u2014 Tigress Financial reiterated its Strong-Buy rating with a price target of US$132.00.<\/p>\n

Geron (GERN)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and lowered its price target to US$2.50 from US$4.00.<\/p>\n

Geron (GERN)<\/strong> \u2014 Wedbush reiterated its Outperform rating.<\/p>\n

Hasbro (HAS)<\/strong> \u2014 UBS Group assigned a Outperform rating and set a price target to US$21.00 from US$28.00.<\/p>\n

HCA Healthcare (HCA)<\/strong> \u2014 Bank of America maintained its Neutral rating and raised its price target to US$500.00 from US$450.00.<\/p>\n

HCA Healthcare (HCA)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to US$490.00 from US$435.00.<\/p>\n

HCA Healthcare (HCA)<\/strong> \u2014 Mizuho set a price target to US$495.00.<\/p>\n

HCA Healthcare (HCA)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to US$409.00 from US$393.00.<\/p>\n

HCA Healthcare (HCA)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$486.00 from US$460.00.<\/p>\n

Herc (HRI)<\/strong> \u2014 Barclays reiterated its Overweight rating with a price target of US$200.00.<\/p>\n

Herc (HRI)<\/strong> \u2014 BNP Paribas Exane maintained its Neutral rating and raised its price target to US$176.00 from US$165.00.<\/p>\n

Herc (HRI)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$230.00 from US$165.00.<\/p>\n

Herc (HRI)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to US$240.00 from US$220.00.<\/p>\n

Herc (HRI)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$200.00 from US$176.00.<\/p>\n

Hexcel (HXL)<\/strong> \u2014 TD Cowen reiterated its Hold rating.<\/p>\n

HF Sinclair (DINO)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating with a price target of US$50.00 from US$62.00.<\/p>\n

Hilton Worldwide (HLT)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$362.00 from US$349.00.<\/p>\n

Hilton Worldwide (HLT)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to US$362.00 from US$360.00.<\/p>\n

Hilton Worldwide (HLT)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to US$360.00 from US$345.00.<\/p>\n

Hilton Worldwide (HLT)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a price target of US$390.00.<\/p>\n

Hilton Worldwide (HLT)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$386.00 from US$383.00.<\/p>\n

Hubbell (HUBB)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Neutral rating and raised its price target to US$486.00 from US$485.00.<\/p>\n

Hubbell (HUBB)<\/strong> \u2014 Mizuho set a price target to US$515.00.<\/p>\n

Hubbell (HUBB)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and lowered its price target to US$540.00 from US$550.00.<\/p>\n

Hubbell (HUBB)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$525.00 from US$531.00.<\/p>\n

HubSpot (HUBS)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$250.00 from US$200.00.<\/p>\n

Huntington Bancshares (HBAN)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to US$18.00 from US$19.00.<\/p>\n

Icon (ICLR)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

Illinois Tool Works (ITW)<\/strong> \u2014 Truist Financial reiterated its Hold rating with a price target of US$293.00 from US$297.00.<\/p>\n

Independent Bank (IBCP)<\/strong> \u2014 DA Davidson maintained its Neutral rating and raised its price target to US$42.00 from US$40.00.<\/p>\n

Indivior (INDV)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$45.00 from US$43.00.<\/p>\n

Innio (INIO)<\/strong> \u2014 Citigroup reiterated its Neutral rating.<\/p>\n

Innio (INIO)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$42.00 from US$40.00.<\/p>\n

Intapp (INTA)<\/strong> \u2014 Citigroup reiterated its Neutral rating.<\/p>\n

Intapp (INTA)<\/strong> \u2014 Oppenheimer reiterated its Market Perform rating.<\/p>\n

Intapp (INTA)<\/strong> \u2014 UBS Group reiterated its Mixed rating.<\/p>\n

Invesco (IVZ)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to US$33.00 from US$32.00.<\/p>\n

IQVIA (IQV)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$325.00 from US$295.00.<\/p>\n

IQVIA (IQV)<\/strong> \u2014 Truist Financial maintained its Buy rating and raised its price target to US$346.00 from US$329.00.<\/p>\n

Itron (ITRI)<\/strong> \u2014 BNP Paribas Exane maintained its Outperform rating and lowered its price target to US$105.00 from US$115.00.<\/p>\n

Itron (ITRI)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$109.00 from US$107.00.<\/p>\n

Itron (ITRI)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

Jazz Pharmaceuticals (JAZZ)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$300.00 from US$276.00.<\/p>\n

JFrog (FROG)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to US$125.00 from US$115.00.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 BNP Paribas Exane maintained its Underperform rating and raised its price target to US$145.00 from US$130.00.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 Evercore set a price target to US$170.00.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to US$172.00 from US$162.00.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

Johnson Controls International (JCI)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$200.00 from US$186.00.<\/p>\n

Karman (KRMN)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$60.00 from US$70.00.<\/p>\n

Kimberly-Clark (KMB)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a price target of US$113.00.<\/p>\n

Kinder Morgan (KMI)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$38.00 from US$36.00.<\/p>\n

Kiniksa Pharmaceuticals International (KNSA)<\/strong> \u2014 The Goldman Sachs Group maintained its Buy rating and raised its price target to US$101.00 from US$90.00.<\/p>\n

Kiniksa Pharmaceuticals International (KNSA)<\/strong> \u2014 Wedbush maintained its Outperform rating and raised its price target to US$102.00 from US$99.00.<\/p>\n

Kiniksa Pharmaceuticals International (KNSA)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$110.00 from US$87.00.<\/p>\n

Klaviyo (KVYO)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Klaviyo (KVYO)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$24.00 from US$22.00.<\/p>\n

Kosmos Energy (KOS)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold with a price target of US$2.90.<\/p>\n

Kratos Defense & Security Solutions (KTOS)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$55.00 from US$80.00.<\/p>\n

Labcorp (LH)<\/strong> \u2014 Barclays set a price target to US$380.00.<\/p>\n

Labcorp (LH)<\/strong> \u2014 Leerink Partners set a price target to US$410.00.<\/p>\n

Lakeland Financial (LKFN)<\/strong> \u2014 Stephens maintained its Equal Weight rating and raised its price target to US$67.00 from US$66.00.<\/p>\n

Lakewood-Amedex Biotherapeutics (LABT)<\/strong> \u2014 H.C. Wainwright initiated coverage with a Buy rating with a price target of US$3.<\/p>\n

Lamar Advertising (LAMR)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$156.00 from US$151.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 Evercore set a price target to US$182.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 Raymond James Financial reiterated its Market Perform rating.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and lowered its price target to US$195.00 from US$215.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 Stephens maintained its Overweight rating and lowered its price target to US$210.00 from US$215.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to US$179.00 from US$197.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to US$160.00 from US$175.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 UBS Group set a price target to US$185.00.<\/p>\n

Landstar System (LSTR)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$215.00 from US$225.00.<\/p>\n

Liftoff Mobile (LFTO)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$21.00 from US$34.00.<\/p>\n

Lincoln Educational Services (LINC)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$52.00 from US$56.00.<\/p>\n

Lincoln Electric (LECO)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$293.00 from US$283.00.<\/p>\n

Lincoln Electric (LECO)<\/strong> \u2014 Robert W. Baird maintained its Outperform rating and raised its price target to US$322.00 from US$317.00.<\/p>\n

Lincoln Electric (LECO)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and raised its price target to US$290.00 from US$271.00.<\/p>\n

Lincoln Electric (LECO)<\/strong> \u2014 UBS Group reiterated its Buy rating with a price target of US$360.00.<\/p>\n

Logitech International (LOGI)<\/strong> \u2014 Barclays maintained its Equal Weight rating and raised its price target to US$110.00 from US$101.00.<\/p>\n

Logitech International (LOGI)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$94.00 from US$90.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$372.00 from US$409.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 TD Cowen maintained its Hold rating and lowered its price target to US$356.00 from US$380.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a price target of US$400.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to US$335.00 from US$354.00.<\/p>\n

LPL Financial (LPLA)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$350.00 from US$362.00.<\/p>\n

Manhattan Associates (MANH)<\/strong> \u2014 DA Davidson maintained its Neutral rating and raised its price target to US$230.00 from US$210.00.<\/p>\n

Manhattan Associates (MANH)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to US$300.00 from US$250.00.<\/p>\n

Manhattan Associates (MANH)<\/strong> \u2014 Truist Financial reiterated its Buy rating with a price target of US$305.00 from US$240.00.<\/p>\n

Manhattan Associates (MANH)<\/strong> \u2014 UBS Group set a price target to US$305.00.<\/p>\n

Manulife Financial (MFC)<\/strong> \u2014 Scotiabank downgraded the stock from Sector Outperform to Sector Perform.<\/p>\n

Martin Marietta Materials (MLM)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to US$629.00 from US$634.00.<\/p>\n

Marzetti (MZTI)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$135.00 from US$140.00.<\/p>\n

Match Group (MTCH)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$39.00 from US$40.00.<\/p>\n

Mercury Systems (MRCY)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$105.00 from US$120.00.<\/p>\n

MidCap Financial Investment (MFIC)<\/strong> \u2014 Raymond James Financial downgraded the stock from Outperform to Market Perform.<\/p>\n

Monarch Casino & Resort (MCRI)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to US$123.00 from US$128.00.<\/p>\n

MSG Rangers Corp (MSGR)<\/strong> \u2014 Guggenheim initiated coverage with a Buy rating with a price target of US$278.<\/p>\n

National Research (NRC)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and raised its price target to US$27.00 from US$26.00.<\/p>\n

Neurogene (NGNE)<\/strong> \u2014 HC Wainwright reiterated its Buy rating with a price target of US$8.00 from US$10.00.<\/p>\n

Noble (NE)<\/strong> \u2014 Susquehanna maintained its Neutral rating and raised its price target to US$46.00 from US$44.00.<\/p>\n

Northern Oil and Gas (NOG)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating with a price target of US$34.00.<\/p>\n

Novartis (NVS)<\/strong> \u2014 Morgan Stanley reiterated its Overweight rating with a price target of US$163.00.<\/p>\n

Novartis (NVS)<\/strong> \u2014 Royal Bank Of Canada reiterated its Sector Perform rating.<\/p>\n

Novartis (NVS)<\/strong> \u2014 UBS Group reiterated its Neutral rating.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a price target to US$159.00.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and lowered its price target to US$149.00 from US$162.00.<\/p>\n

NRG Energy (NRG)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$182.00 from US$209.00.<\/p>\n

Nucor (NUE)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$320.00 from US$306.00.<\/p>\n

Nucor (NUE)<\/strong> \u2014 JPMorgan Chase & Co. maintained its Overweight rating and raised its price target to US$304.00 from US$296.00.<\/p>\n

Nucor (NUE)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a price target of US$335.00.<\/p>\n

Nucor (NUE)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$305.00 from US$280.00.<\/p>\n

NuScale Power (SMR)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$10.00 from US$15.00.<\/p>\n

Nutrien (NTR)<\/strong> \u2014 Raymond James Financial maintained its Outperform rating and lowered its price target to US$83.00 from US$90.00.<\/p>\n

nVent Electric (NVT)<\/strong> \u2014 Roth Capital set a price target to US$200.00.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Bank of America reiterated its Neutral rating with a price target of US$280.00.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Citigroup reiterated its Neutral rating.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to US$330.00 from US$345.00.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$313.00 from US$338.00.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating with a price target of US$300.00.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to US$250.00 from US$265.00.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$280.00 from US$275.00.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to US$300.00 from US$310.00.<\/p>\n

NXP Semiconductors (NXPI)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$245.00 from US$235.00.<\/p>\n

OGE Energy (OGE)<\/strong> \u2014 Scotiabank reiterated its Outperform rating with a price target of US$54.00.<\/p>\n

Oklo (OKLO)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$61.00 from US$92.00.<\/p>\n

Omada Health (OMDA)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$24.00 from US$27.00.<\/p>\n

ON (ONON)<\/strong> \u2014 BMO Capital Markets reiterated its Market Perform rating with a price target of US$35.00.<\/p>\n

OneSpaWorld (OSW)<\/strong> \u2014 Jefferies Financial Group reiterated its Buy rating with a price target of US$40.00.<\/p>\n

Oric Pharmaceuticals (ORIC)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a price target of US$26.00.<\/p>\n

OrthoPediatrics (KIDS)<\/strong> \u2014 BTIG Research maintained its Buy rating and raised its price target to US$30.00 from US$29.00.<\/p>\n

OrthoPediatrics (KIDS)<\/strong> \u2014 Canaccord Genuity Group set a price target to US$30.00.<\/p>\n

OrthoPediatrics (KIDS)<\/strong> \u2014 Lake Street Capital reiterated its Buy rating with a price target of US$38.00.<\/p>\n

OrthoPediatrics (KIDS)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating with a price target of US$35.00.<\/p>\n

OrthoPediatrics (KIDS)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating with a price target of US$30.00 from US$25.00.<\/p>\n

OrthoPediatrics (KIDS)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to US$27.00 from US$24.00.<\/p>\n

OrthoPediatrics (KIDS)<\/strong> \u2014 TD Cowen maintained its Buy rating and raised its price target to US$28.00 from US$23.00.<\/p>\n

OrthoPediatrics (KIDS)<\/strong> \u2014 Truist Financial maintained its Hold rating and raised its price target to US$28.00 from US$22.00.<\/p>\n

Ovintiv (OVV)<\/strong> \u2014 National Bank Financial maintained its Outperform rating and raised its price target to US$95.00 from US$94.00.<\/p>\n

PACCAR (PCAR)<\/strong> \u2014 Truist Financial maintained its Hold rating and lowered its price target to US$124.00 from US$125.00.<\/p>\n

Palantir Technologies (PLTR)<\/strong> \u2014 Royal Bank Of Canada reiterated its Underperform rating.<\/p>\n

Palvella Therapeutics (PVLA)<\/strong> \u2014 Chardan Capital reiterated its Buy rating with a price target of US$240.00.<\/p>\n

Park National (PRK)<\/strong> \u2014 Piper Sandler maintained its Neutral rating and lowered its price target to US$201.00 from US$217.00.<\/p>\n

Paycom Software (PAYC)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to US$295.00 from US$280.00.<\/p>\n

Paylocity (PCTY)<\/strong> \u2014 KeyCorp maintained its Overweight rating and raised its price target to US$190.00 from US$178.00.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 Bank of America maintained its Underperform rating and raised its price target to US$54.00 from US$53.00.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 BMO Capital Markets maintained its Market Perform rating and raised its price target to US$59.00 from US$56.00.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 Canaccord Genuity Group reiterated its Hold rating with a price target of US$55.00.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 Morgan Stanley maintained its Underweight rating and raised its price target to US$46.00 from US$45.00.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$60.00 from US$59.00.<\/p>\n

PayPal (PYPL)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a price target of US$60.00.<\/p>\n

Pentair (PNR)<\/strong> \u2014 BNP Paribas Exane upgraded the stock from Underperform to Neutral with a price target of US$65.00.<\/p>\n

Pentair (PNR)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

Pentair (PNR)<\/strong> \u2014 Robert W. Baird set a price target to US$78.00.<\/p>\n

Pentair (PNR)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$69.00 from US$61.00.<\/p>\n

Pentair (PNR)<\/strong> \u2014 The Goldman Sachs Group set a price target to US$66.00.<\/p>\n

Pentair (PNR)<\/strong> \u2014 UBS Group set a price target to US$65.00.<\/p>\n

Pharming Group (PHAR)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

Phoenix Education Partners (PXED)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$44.00 from US$51.00.<\/p>\n

Pinnacle Financial Partners (PNFP)<\/strong> \u2014 Truist Financial maintained its Buy rating and raised its price target to US$120.00 from US$112.00.<\/p>\n

Pinterest (PINS)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to US$28.00 from US$30.00.<\/p>\n

Polaris (PII)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$72.00 from US$75.00.<\/p>\n

Precision Drilling (PDS)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n

Principal Financial Group (PFG)<\/strong> \u2014 Evercore set a price target to US$111.00.<\/p>\n

Principal Financial Group (PFG)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and lowered its price target to US$125.00 from US$128.00.<\/p>\n

Principal Financial Group (PFG)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$109.00 from US$112.00.<\/p>\n

Procore Technologies (PCOR)<\/strong> \u2014 Griffin Securities initiated coverage with a Buy rating with a price target of US$82.00.<\/p>\n

Prudential Financial (PRU)<\/strong> \u2014 Wells Fargo & Company maintained its Underweight rating and lowered its price target to US$103.00 from US$104.00.<\/p>\n

Public Storage (PSA)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and raised its price target to US$323.00 from US$318.00.<\/p>\n

Pulmonx (LUNG)<\/strong> \u2014 Canaccord Genuity Group set a price target to US$5.00.<\/p>\n

Pulmonx (LUNG)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and raised its price target to US$4.00 from US$2.50.<\/p>\n

Qiagen (QGEN)<\/strong> \u2014 Barclays downgraded the stock from Overweight to Equal Weight with a price target of US$53.00 from US$55.00.<\/p>\n

Ralph Lauren (RL)<\/strong> \u2014 UBS Group reiterated its Buy rating with a price target of US$521.00.<\/p>\n

Repligen (RGEN)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and raised its price target to US$200.00 from US$185.00.<\/p>\n

Revolve Group (RVLV)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a price target of US$35.00.<\/p>\n

Ribbon Communications (RBBN)<\/strong> \u2014 B. Riley Financial reiterated its Buy rating with a price target of US$3.10 from US$3.30.<\/p>\n

Ribbon Communications (RBBN)<\/strong> \u2014 Rosenblatt Securities maintained its Neutral rating and lowered its price target to US$1.80 from US$2.20.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$115.00 from US$132.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a price target of US$135.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Citizens Jmp reiterated its Market Outperform rating with a price target of US$165.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 KeyCorp maintained its Overweight rating and lowered its price target to US$135.00 from US$140.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and lowered its price target to US$116.00 from US$126.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Rosenblatt Securities reiterated its Buy rating with a price target of US$135.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and lowered its price target to US$124.00 from US$136.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 The Goldman Sachs Group maintained its Buy rating and lowered its price target to US$128.00 from US$145.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to US$125.00 from US$134.00.<\/p>\n

Robinhood Markets (HOOD)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$100.00 from US$120.00.<\/p>\n

Roblox (RBLX)<\/strong> \u2014 BTIG Research maintained its Sell rating and raised its price target to US$42.00 from US$41.00.<\/p>\n

Rocky Brands (RCKY)<\/strong> \u2014 BTIG Research reiterated its Neutral rating.<\/p>\n

Rocky Brands (RCKY)<\/strong> \u2014 Robert W. Baird maintained its Neutral rating and raised its price target to US$52.00 from US$50.00.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$350.00 from US$337.00.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 Susquehanna maintained its Positive rating and raised its price target to US$360.00 from US$355.00.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 The Goldman Sachs Group reiterated its Buy rating with a price target of US$358.00.<\/p>\n

Royal Caribbean Cruises (RCL)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$361.00 from US$358.00.<\/p>\n

Ryanair (RYAAY)<\/strong> \u2014 Oddo Bhf downgraded the stock from Outperform to Underperform.<\/p>\n

S&P Global (SPGI)<\/strong> \u2014 Citigroup reiterated its Buy rating.<\/p>\n

S&P Global (SPGI)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

S&P Global (SPGI)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and raised its price target to US$515.00 from US$477.00.<\/p>\n

S&P Global (SPGI)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and raised its price target to US$545.00 from US$525.00.<\/p>\n

Scorpio Tankers (STNG)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a price target of US$110.00.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$1,148.00 from US$1,200.00.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 Robert W. Baird set a price target to US$1,350.00.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 Summit Insights downgraded the stock from Buy to Hold.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 Susquehanna maintained its Neutral rating and lowered its price target to US$765.00 from US$925.00.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$900.00 from US$1,000.00.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a price target of US$750.00.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 Wedbush reiterated its Outperform rating with a price target of US$1,000.00.<\/p>\n

Seagate Technology (STX)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$820.00 from US$865.00.<\/p>\n

Sensata Technologies (ST)<\/strong> \u2014 Truist Financial maintained its Buy rating and lowered its price target to US$57.00 from US$58.00.<\/p>\n

SharkNinja (SN)<\/strong> \u2014 Piper Sandler maintained its Overweight rating and raised its price target to US$234.00 from US$200.00.<\/p>\n

Sherwin-Williams (SHW)<\/strong> \u2014 Barclays assigned a Equal Weight rating and set a price target to US$329.00 from US$348.00.<\/p>\n

Sherwin-Williams (SHW)<\/strong> \u2014 DA Davidson assigned a Buy rating and set a price target to US$390.00 from US$400.00.<\/p>\n

Sherwin-Williams (SHW)<\/strong> \u2014 Guggenheim reiterated its Buy rating with a price target of US$375.00 from US$400.00.<\/p>\n

Sherwin-Williams (SHW)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a price target of US$370.00.<\/p>\n

Silicon Motion Technology (SIMO)<\/strong> \u2014 China Renaissance initiated coverage with a Buy rating with a price target of US$300.00.<\/p>\n

Simply Good Foods (SMPL)<\/strong> \u2014 Jefferies Financial Group downgraded the stock from Buy to Hold with a price target of US$11.00.<\/p>\n

Simply Good Foods (SMPL)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to US$18.00 from US$20.00.<\/p>\n

Simply Good Foods (SMPL)<\/strong> \u2014 UBS Group reiterated its Neutral rating, and\u00a0set a price target to US$11.00.<\/p>\n

SK hynix (SKHY)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and raised its price target to US$235.00 from US$220.00.<\/p>\n

SK hynix (SKHY)<\/strong> \u2014 Rosenblatt Securities maintained its Buy rating and raised its price target to US$400.00 from US$320.00.<\/p>\n

SK hynix (SKHY)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating with a price target of US$200.00.<\/p>\n

SK hynix (SKHY)<\/strong> \u2014 Wells Fargo & Company reiterated its Buy rating.<\/p>\n

SK hynix (SKHY)<\/strong> \u2014 Wolfe Research reiterated its Outperform rating.<\/p>\n

Slide Insurance (SLDE)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$30.00 from US$28.00.<\/p>\n

Slide Insurance (SLDE)<\/strong> \u2014 Citizens Jmp maintained its Market Outperform rating and raised its price target to US$33.00 from US$28.00.<\/p>\n

Smithfield Foods (SFD)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$23.00 from US$29.00.<\/p>\n

Smithfield Foods (SFD)<\/strong> \u2014 Stephens reiterated its Reduce rating.<\/p>\n

Smithfield Foods (SFD)<\/strong> \u2014 Stephens maintained its Equal Weight rating and lowered its price target to US$20.00 from US$22.00.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 Bank of America reiterated its Underperform rating with a price target of US$16.50.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 Benchmark reiterated its Sector Outperform rating.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 Keefe, Bruyette & Woods maintained its Underperform rating and raised its price target to US$16.00 from US$15.00.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 Needham & Company LLC reiterated its Buy rating with a price target of US$24.00.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 Scotiabank reiterated its Sector Outperform rating with a price target of US$26.00 from US$25.00.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$18.00 from US$17.50.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 Wells Fargo & Company reiterated its Negative rating.<\/p>\n

SoFi Technologies (SOFI)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$18.00 from US$17.00.<\/p>\n

SoftBank Group (SFTBY)<\/strong> \u2014 Jefferies upgraded the stock from Underperform to Hold.<\/p>\n

Solventum (SOLV)<\/strong> \u2014 CIBC set a price target to US$35.00.<\/p>\n

Spero Therapeutics (SPRO)<\/strong> \u2014 Cantor Fitzgerald initiated coverage with a Buy rating with a price target of US$118.00 from US$113.00.<\/p>\n

StandardAero (SARO)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$32.00 from US$34.00.<\/p>\n

Sun Communities (SUI)<\/strong> \u2014 Evercore reiterated its Outperform rating.<\/p>\n

Sun Life Financial (SLF)<\/strong> \u2014 Scotiabank upgraded the stock from Sector Perform to Sector Outperform.<\/p>\n

Sweetgreen (SG)<\/strong> \u2014 UBS Group reiterated its Neutral rating with a price target of US$11.00.<\/p>\n

Talen Energy (TLN)<\/strong> \u2014 CIBC reiterated its Outperform rating with a price target of US$493.00.<\/p>\n

Talen Energy (TLN)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$479.00 from US$501.00.<\/p>\n

TAT Technologies (TATT)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$60.00 from US$65.00.<\/p>\n

Texas Instruments (TXN)<\/strong> \u2014 DZ Bank upgraded the stock from Sell to Hold with a price target of US$300.00.<\/p>\n

Thomson Reuters (TRI)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and raised its price target to US$130.00 from US$124.00.<\/p>\n

Thryv (THRY)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$2.00 from US$3.00.<\/p>\n

Titan America (TTAM)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to US$17.00 from US$19.00.<\/p>\n

TPG RE Finance Trust (TRTX)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$8.00 from US$9.00.<\/p>\n

TransUnion (TRU)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and raised its price target to US$95.00 from US$85.00.<\/p>\n

TransUnion (TRU)<\/strong> \u2014 Robert W. Baird set a price target to US$99.00.<\/p>\n

TransUnion (TRU)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to US$90.00 from US$96.00.<\/p>\n

TransUnion (TRU)<\/strong> \u2014 The Goldman Sachs Group maintained its Neutral rating and raised its price target to US$78.00 from US$68.00.<\/p>\n

TransUnion (TRU)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$96.00 from US$102.00.<\/p>\n

Travel + Leisure (TNL)<\/strong> \u2014 Barclays maintained its Equal Weight rating and lowered its price target to US$72.00 from US$77.00.<\/p>\n

Travel + Leisure (TNL)<\/strong> \u2014 Mizuho set a price target to US$108.00.<\/p>\n

Ultra Clean (UCTT)<\/strong> \u2014 Needham & Company LLC maintained its Buy rating and lowered its price target to US$80.00 from US$125.00.<\/p>\n

Ultra Clean (UCTT)<\/strong> \u2014 TD Cowen maintained its Buy rating and lowered its price target to US$100.00 from US$140.00.<\/p>\n

Ultra Clean (UCTT)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

Under Armour (UAA)<\/strong> \u2014 UBS Group reiterated its Buy rating.<\/p>\n

United Parcel Service (UPS)<\/strong> \u2014 Bank of America maintained its Neutral rating and raised its price target to US$114.00 from US$108.00.<\/p>\n

United Parcel Service (UPS)<\/strong> \u2014 Barclays maintained its Underweight rating and raised its price target to US$95.00 from US$80.00.<\/p>\n

United Parcel Service (UPS)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to US$119.00 from US$117.00.<\/p>\n

United Parcel Service (UPS)<\/strong> \u2014 TD Cowen maintained its Hold rating and raised its price target to US$116.00 from US$115.00.<\/p>\n

United Parcel Service (UPS)<\/strong> \u2014 Truist Financial maintained its Buy rating and raised its price target to US$120.00 from US$115.00.<\/p>\n

United Parcel Service (UPS)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and raised its price target to US$112.00 from US$110.00.<\/p>\n

Universal Technical Institute (UTI)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$45.00 from US$48.00.<\/p>\n

Urogen Pharma (URGN)<\/strong> \u2014 Oppenheimer reiterated its Outperform rating.<\/p>\n

V.F. (VFC)<\/strong> \u2014 BTIG Research reiterated its Buy rating with a price target of US$23.00.<\/p>\n

V2X (VVX)<\/strong> \u2014 Royal Bank Of Canada maintained its Sector Perform rating and lowered its price target to US$81.00 from US$88.00.<\/p>\n

Veeva Systems (VEEV)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$375.00 from US$360.00.<\/p>\n

Victory Capital (VCTR)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and raised its price target to US$119.00 from US$115.00.<\/p>\n

Visa (V)<\/strong> \u2014 Barclays maintained its Overweight rating and raised its price target to US$440.00 from US$420.00.<\/p>\n

Visa (V)<\/strong> \u2014 BMO Capital Markets assigned a Outperform rating and set a price target to US$438.00 from US$425.00.<\/p>\n

Visa (V)<\/strong> \u2014 Cantor Fitzgerald reiterated its Overweight rating.<\/p>\n

Visa (V)<\/strong> \u2014 Evercore set a price target to US$405.00.<\/p>\n

Visa (V)<\/strong> \u2014 Morgan Stanley reiterated its Overweight rating with a price target of US$471.00 from US$416.00.<\/p>\n

Visa (V)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and raised its price target to US$440.00 from US$403.00.<\/p>\n

Visa (V)<\/strong> \u2014 Piper Sandler reiterated its Overweight rating with a price target of US$479.00 from US$430.00.<\/p>\n

Visa (V)<\/strong> \u2014 Raymond James Financial reiterated its Outperform rating with a price target of US$445.00.<\/p>\n

Visa (V)<\/strong> \u2014 Royal Bank Of Canada reiterated its Outperform rating with a price target of US$466.00.<\/p>\n

Visa (V)<\/strong> \u2014 TD Cowen reiterated its Buy rating with a price target of US$450.00 from US$420.00.<\/p>\n

Visteon (VC)<\/strong> \u2014 Barclays maintained its Overweight rating and lowered its price target to US$105.00 from US$125.00.<\/p>\n

Vistra (VST)<\/strong> \u2014 Canadian Imperial Bank of Commerce set a price target to US$181.00.<\/p>\n

Vistra (VST)<\/strong> \u2014 Scotiabank maintained its Sector Outperform rating and lowered its price target to US$189.00 from US$207.00.<\/p>\n

Vistra (VST)<\/strong> \u2014 Wells Fargo & Company maintained its Overweight rating and lowered its price target to US$198.00 from US$212.00.<\/p>\n

VSE (VSEC)<\/strong> \u2014 B. Riley Financial maintained its Buy rating and lowered its price target to US$265.00 from US$280.00.<\/p>\n

VSE (VSEC)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$220.00 from US$265.00.<\/p>\n

Vulcan Materials (VMC)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to US$320.00 from US$333.00.<\/p>\n

W.P. Carey (WPC)<\/strong> \u2014 BMO Capital Markets reiterated its Outperform rating.<\/p>\n

Wendy’s (WEN)<\/strong> \u2014 TD Cowen reiterated its Hold rating with a price target of US$6.00.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$52.00 from US$55.00.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Stephens maintained its Overweight rating and lowered its price target to US$38.00 from US$46.00.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Stifel Nicolaus maintained its Hold rating and lowered its price target to US$36.00 from US$40.00.<\/p>\n

Werner Enterprises (WERN)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$31.00 from US$35.00.<\/p>\n

Whirlpool (WHR)<\/strong> \u2014 Royal Bank Of Canada maintained its Underperform rating and lowered its price target to US$15.00 from US$22.00.<\/p>\n

Whirlpool (WHR)<\/strong> \u2014 Stifel Nicolaus downgraded the stock from Hold to Sell with a price target of US$20.00 from US$30.00.<\/p>\n

Whirlpool (WHR)<\/strong> \u2014 Wells Fargo & Company maintained its Equal Weight rating and lowered its price target to US$24.00 from US$30.00.<\/p>\n

WisdomTree (WT)<\/strong> \u2014 Morgan Stanley maintained its Equal Weight rating and lowered its price target to US$25.00 from US$27.00.<\/p>\n

Woodward (WWD)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$380.00 from US$430.00.<\/p>\n

Wyndham Hotels & Resorts (WH)<\/strong> \u2014 Morgan Stanley maintained its Overweight rating and lowered its price target to US$94.00 from US$97.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 BNP Paribas Exane maintained its Outperform rating and lowered its price target to US$135.00 from US$145.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 JPMorgan Chase & Co. downgraded the stock from Overweight to Neutral with a price target of US$90.00 from US$118.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Mizuho set a price target to US$99.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Oppenheimer maintained its Outperform rating and lowered its price target to US$135.00 from US$150.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Robert W. Baird set a price target to US$123.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Royal Bank Of Canada maintained its Outperform rating and lowered its price target to US$125.00 from US$135.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 Stifel Nicolaus maintained its Buy rating and lowered its price target to US$114.00 from US$141.00.<\/p>\n

Xylem (XYL)<\/strong> \u2014 The Goldman Sachs Group maintained its Buy rating and lowered its price target to US$138.00 from US$160.00.<\/p>\n","protected":false},"excerpt":{"rendered":"

Analyst Ratings (USA) Today’s updates reflect a selective analyst outlook, with confidence in software, semiconductors and payments sectors, offset by caution toward industrials, solar…<\/p>\n","protected":false},"author":3,"featured_media":9760,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[1],"tags":[],"class_list":["post-76748","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog"],"acf":[],"yoast_head":"\nAmerican Analyst Updates: Oct 28th, 2026 | Stock Target Advisor<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"American Analyst Updates: Oct 28th, 2026\" \/>\n<meta property=\"og:description\" content=\"Analyst Ratings (USA) Today’s updates reflect a selective analyst outlook, with confidence in software, semiconductors and payments sectors, offset by caution toward industrials, solar…\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/\" \/>\n<meta property=\"og:site_name\" content=\"Stock Target Advisor\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\" \/>\n<meta property=\"article:published_time\" content=\"2026-10-28T20:13:20+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2022\/02\/robinhood-banner.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"840\" \/>\n\t<meta property=\"og:image:height\" content=\"410\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"STA Research\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:site\" content=\"@AdvisorTarget\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"STA Research\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"35 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/\"},\"author\":{\"name\":\"STA Research\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\"},\"headline\":\"American Analyst Updates: Oct 28th, 2026\",\"datePublished\":\"2026-10-28T20:13:20+00:00\",\"dateModified\":\"2026-10-28T20:13:20+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/\"},\"wordCount\":7993,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"articleSection\":[\"Market News & Insights\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/\",\"name\":\"American Analyst Updates: Oct 28th, 2026 | Stock Target Advisor\",\"isPartOf\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\"},\"datePublished\":\"2026-10-28T20:13:20+00:00\",\"dateModified\":\"2026-10-28T20:13:20+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"American Analyst Updates: Oct 28th, 2026\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#website\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"name\":\"Stock Target Advisor\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#organization\",\"name\":\"Stock Target Advisor\",\"alternateName\":\"STA\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\",\"url\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"contentUrl\":\"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg\",\"width\":\"225\",\"height\":\"225\",\"caption\":\"Stock Target Advisor\"},\"image\":{\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/StockTargetAdvisor\/\",\"https:\/\/twitter.com\/AdvisorTarget\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae\",\"name\":\"STA Research\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g\",\"caption\":\"STA Research\"},\"description\":\"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.\",\"url\":\"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"American Analyst Updates: Oct 28th, 2026 | Stock Target Advisor","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/","og_locale":"en_US","og_type":"article","og_title":"American Analyst Updates: Oct 28th, 2026","og_description":"Analyst Ratings (USA) Today’s updates reflect a selective analyst outlook, with confidence in software, semiconductors and payments sectors, offset by caution toward industrials, solar…","og_url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/","og_site_name":"Stock Target Advisor","article_publisher":"https:\/\/www.facebook.com\/StockTargetAdvisor\/","article_published_time":"2026-10-28T20:13:20+00:00","og_image":[{"width":840,"height":410,"url":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-content\/uploads\/2022\/02\/robinhood-banner.jpg","type":"image\/jpeg"}],"author":"STA Research","twitter_card":"summary_large_image","twitter_creator":"@AdvisorTarget","twitter_site":"@AdvisorTarget","twitter_misc":{"Written by":"STA Research","Est. reading time":"35 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/#article","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/"},"author":{"name":"STA Research","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae"},"headline":"American Analyst Updates: Oct 28th, 2026","datePublished":"2026-10-28T20:13:20+00:00","dateModified":"2026-10-28T20:13:20+00:00","mainEntityOfPage":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/"},"wordCount":7993,"commentCount":0,"publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"articleSection":["Market News & Insights"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/","url":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/","name":"American Analyst Updates: Oct 28th, 2026 | Stock Target Advisor","isPartOf":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website"},"datePublished":"2026-10-28T20:13:20+00:00","dateModified":"2026-10-28T20:13:20+00:00","breadcrumb":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/american-analyst-updates-oct-28th-2026\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.stocktargetadvisor.com\/blog\/"},{"@type":"ListItem","position":2,"name":"American Analyst Updates: Oct 28th, 2026"}]},{"@type":"WebSite","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#website","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","name":"Stock Target Advisor","description":"","publisher":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.stocktargetadvisor.com\/blog\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#organization","name":"Stock Target Advisor","alternateName":"STA","url":"https:\/\/www.stocktargetadvisor.com\/blog\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/","url":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","contentUrl":"http:\/\/stocktargetadvisor.com\/wp-content\/uploads\/2019\/10\/STAlogo.jpeg","width":"225","height":"225","caption":"Stock Target Advisor"},"image":{"@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/StockTargetAdvisor\/","https:\/\/twitter.com\/AdvisorTarget"]},{"@type":"Person","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/e15ebb81d4f6861fcecbe1abc54e1cae","name":"STA Research","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.stocktargetadvisor.com\/blog\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/13a95c75b44f95ead23f47f0bf10667e57b44ec5150180c8a39a39361cf56169?s=96&d=mm&r=g","caption":"STA Research"},"description":"STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.","url":"https:\/\/www.stocktargetadvisor.com\/blog\/author\/sta-research\/"}]}},"_links":{"self":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76748","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/comments?post=76748"}],"version-history":[{"count":4,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76748\/revisions"}],"predecessor-version":[{"id":76758,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/posts\/76748\/revisions\/76758"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media\/9760"}],"wp:attachment":[{"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/media?parent=76748"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/categories?post=76748"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.stocktargetadvisor.com\/blog\/wp-json\/wp\/v2\/tags?post=76748"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}